Author(s):
Darpelly Mahesh, Gautam Kumar, Ashok Kumar Gupta, Vijay Kumar Singh, Veena Devi Singh
Email(s):
ashokg195@gmail.com
DOI:
10.52711/0974-360X.2025.00129 
Address:
Darpelly Mahesh1, Gautam Kumar2, Ashok Kumar Gupta3*, Vijay Kumar Singh4, Veena Devi Singh4
1Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, India.
2School of Pharmaceutical Sciences, Apeejay Stya University, Gurugram, Haryana, India.
3School of Pharmacy, Sharda University, Knowledge Park-3, Greater Noida, U.P., 201306, India.
4Shri Rawatpura Sarkar College of Pharmacy, Shri Rawatpura Sarkar University, Dhaneli, Raipur, CG., 492015, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 2,
Year - 2025
ABSTRACT:
Background: The ability of obesity indices to predict cardiovascular risk in type 2 diabetes mellitus (T2DM) is still debated. This study aims to assess cardiovascular risk factors with anthropometric characterization and obesity indices. Methods: In this observational cross-sectional study, a total of 181 T2DM patients were recruited. Patients were divided based on body mass index (BMI), where normal weight was classified as Group 1 with BMI < 25 kg/m2, n = 94; and overweight as group 2 with BMI = 25 kg/m2, n = 87. Various parameters and their correlations were assessed such as body adiposity index (BAI), visceral adiposity index (VAI), waist circumference (WC), hip circumference (HC), waist/hip ratio (WHR), waist/height ratio (WHtR), Fasting blood sugar (FBS), Postprandial blood sugar (PPBS), ankle-brachial index (ABI) and cardiovascular disease risk factors. Results: Out of 181 T2DM patients, 54.1% of the patients were male. Females had higher mean HC, WHtR, BAI, VAI (all P < 0.001), and WC but lower mean height (P < 0.001), weight (P < 0.05), and WHR. Group 2 patients had higher weight, WC, HC, WHtR, and BAI (all P < 0.001) in comparison to Group 1. Among obesity indices, VAI showed the highest correlation (all P < 0.05) with cardiovascular risk factors. Conclusion: Among all obesity indices VAI showed the highest correlation with cardiovascular risk factors, thus routine measurement of VAI in the clinical setting is advised for the evaluation of T2DM-related complications and cardiovascular risk factors, particularly in women.
Cite this article:
Darpelly Mahesh, Gautam Kumar, Ashok Kumar Gupta, Vijay Kumar Singh, Veena Devi Singh. Assessment of Obesity Indices and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus: A Pilot study from a Tertiary care centre in India. Research Journal of Pharmacy and Technology.2025;18(2):878-4. doi: 10.52711/0974-360X.2025.00129
Cite(Electronic):
Darpelly Mahesh, Gautam Kumar, Ashok Kumar Gupta, Vijay Kumar Singh, Veena Devi Singh. Assessment of Obesity Indices and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus: A Pilot study from a Tertiary care centre in India. Research Journal of Pharmacy and Technology.2025;18(2):878-4. doi: 10.52711/0974-360X.2025.00129 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-2-61
REFERENCES:
1. Amos A, McCarty D, Zimmet P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabetic Med 1997; 14: 1-85.
2. Ramachandran A, Das AK, Joshi SR, Yajnik CS, Shah S, Prasanna KM. Current Status of Diabetes in India and Need for Novel Therapeutic Agents. JAPI 2010; 58: 7-9.
3. Fisher M. Diabetes and atherogenesis. Heart 2004; 90: 336-40.
4. Sprafka JM, Burke GL, Folsom AR, McGovern PG, Hahn LP. Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival: the Minnesota Heart Survey. Diabetes Care 1991; 14: 537-43.
5. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960-67.
6. Peltonen M, Korpi-Hyovalti E, Oksa H. Lihavuuden, diabeteksen ja muiden glukoosiaineenvaihdunnan häiriöiden esiintyvyys suomalaisessa aikuis-väestössä. Suomen Laakarilehti 2006; 61: 163-70.
7. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
8. Parikh RM, Joshi SR, Menon PS, Shah NS. Index of central obesity - A novel parameter. Med Hypotheses 2007; 68: 1272-5.
9. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as and endocrine organ. Mol Cell Endocrinol 2010; 316: 129-39.
10. Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg 1969; 56: 676-9.
11. Cornier MA, Despres JP, Davis N, Grossniklaus DA, Klein S, Lamarche B et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011; 124: 1996-2019.
12. Nyamdorj R, Qiao Q, Lam TH, Tuomilehto J, Ho SY, Pitkäniemi J et al. BMI compared with central obesity indicators in relation to diabetes and hypertension in Asians. Obesity 2008; 16: 1622-35.
13. Langenberg C, Sharp SJ, Schulze MB, Rolandsson O, Overvad K, Forouhi NG et al. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-Inter Act case cohort study. PLoS Med 2012; 9: e1001230.
14. Marco CA, Carla G, Maria P, Aldo G. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population. Lipids Health Dis 2011; 10: 183.
15. Lam BC, Lim SC, Wong MT, Shum E, Ho CY, Bosco JI et al. A method comparison study to validate a novel parameter of obesity, the body adiposity index, in Chinese subjects. Obesity 2013; 21: 634-9.
16. Keppel KG, Pearcy JN, Klein RJ. Measuring progress in healthy people 2010. Stat Notes 2004; 25: 1-16.
17. Jackson CL, Batts-Turner ML, Falb MD, Yeh HC, Brancati FL, Gary TL. Computer and internet use among urban African Americans with type 2 diabetes. J Urban Health 2005; 82: 575-83.
18. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Kostense PJ et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes, the Hoorn Study. Am J Clin Nutr 2003; 77: 1192-7.
19. Rebuffe-Scrive M, Enk L, Crona N, Lönnroth P, Abrahamsson L, Smith U et al. Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest 1985; 75: 1973-6.
20. Meisinger C, Döring A, Thorand B, Heier M, Löwel H. Body fat distribution and risk of type 2 diabetes in the general population, are there differences between men and women? The MONICA/KORA Augsburg cohort study. Am J Clin Nutr 2006; 84: 483-9.
21. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010; 42: 949-60.
22. Haffner SM. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance, epidemiological and clinical correlation. Int J Obes Relat Metab Disord 2000; 24: 56-8.
23. Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG, et al. A better index of body adiposity. Obesity 2011; 19: 1083-9.
24. Suchanek P, Kralova LI, Mengerova O, Mrazkova J, Lanska V, Stavek P. Which index best correlates with body fat mass: BAI, BMI, waist or WHR? Neuro Endocrinol Lett 2012; 2: 78-82.
25. Freedman DS, Thornton JC, Pi-Sunyer FX, Heymsfield SB, Wang J, Pierson RN, Jr et al. The body adiposity index (hip circumference/height (1.5) is not a more accurate measure of adiposity than is BMI, waist circumference, or hip circumference. Obesity 2012; 20: 2438-44.
26. Talaei M, Sadeghi M, Marshall T, Thomas GN, Iranipour R, Nazarat N et al. Anthropometric indices predicting incident type 2 diabetes in an Iranian population: The Isfahan Cohort Study. Diabetes Metab 2013; 39: 424-31.
27. Schulze MB, Thorand B, Fritsche A, Häring HU, Schick F, Zierer A et al. Body adiposity index, body fat content and incidence of type 2 diabetes. Diabetologia 2012; 55: 1660-67.
28. Wang Z, Hoy EW. Association between diabetes and coronary heart disease in Aboriginal people: are women disadvantaged? Med J Aust 2004; 180: 508-11.
29. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes care 1979; 2: 120-6.
30. Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziano JM, Manson JE et al. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 2000; 36: 801-7.
31. Jurado J, Ybarra J, Solanas P, Caula J, Gich I, Pou JM et al. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study. J Am Acad Nurse Pract 2009; 21: 140-48.
32. Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am 2003; 32: 855-67.
33. Unek IT, Bayraktar F, Solmaz D, Ellidokuz H, Sisman AR, Yuksel F et al. The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people. Clin Med Res 2010; 2: 89-95.
34. Knowles KM, Paiva LL, Sanchez SE, Revilla L, Lopez T, Yasuda MB et al. Waist circumference, body mass index, and other measures of adiposity in predicting cardiovascular dis¬ease risk factors among Peruvian adults. Int J Hypertens 2011; 931402.
35. Mastej M, Jóźwiak J, Lukas W. Assessment and comparison of lipid parameters according to sex and body mass index. Kardiol Pol 2006; 64: 153-60.
36. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-93.
37. Garg S, Shankar V, Kutty K, Annamalai N. Relation between anthropometric measurements and serum lipid profile among cardio metabolically healthy subjects: A pilot study. Indian J Endocrinol Metab 2012; 16: 857-58.